Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP ...

CERo Therapeutics (CERO) announces the execution of an agreement with contract research organization CellCarta to manage translational assays ...

Biodexa Pharmaceuticals (BDRX) announced the appointment of Precision for Medicine as the clinical research organization, CRO, to conduct the ...

A detailed review of a 6-month clinical trial further reinforces strong experimental evidence that a ketogenic diet may offer ...

Anova Enterprises, Inc. (Anova), a technology-enabled CRO dedicated to accelerating promising treatments, has announced enrollment of the first two pa ...

Posters presented at the Association of Cancer Care Centers opening session covered initiatives to boost clinical trial ...

Novotech Releases 2025 Report Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced presentation of preclinical data supporting the advancement of ...

Phase Ib trial to evaluate CS5001 in combination with R-CHOP as a first-line treatment for diffuse large B-cell lymphoma (DLBCL), aiming to reshape the standard-of-care landscape. CS5001 is also being ...

The AD/PD™ Conference is an annual event attracting leading medical and scientific professionals from around the world, ...

Melanoma Companies are involved in targeted therapeutics development with respective active and inactive (dormant or ...

Minoryx Therapeutics, a late-stage biotech company focused on the development of therapies for orphan central nervous system ...